VXM01 phase I VEGFR-2 vaccination study in patients with metastatic colorectal cancer with liver metastasis in second or third line therapy

Gruellich, C. and Mikus, G. and Gruen, B. and Beckhove, P. and Podola, L. and Wieckowski, S. and Merz, S. and Kirchner, S. and Sifre-Maunier, L. and Springfeld, C. and Lubenau, H. and Haefeli, W. and Jaeger, D. (2017) VXM01 phase I VEGFR-2 vaccination study in patients with metastatic colorectal cancer with liver metastasis in second or third line therapy. ONCOLOGY RESEARCH AND TREATMENT, 40 (Suppl3). p. 213. ISSN 2296-5270, 2296-5262

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Zentren des Universitätsklinikums Regensburg > Regensburger Centrum für Interventionelle Immunologie (RCI)
Depositing User: Petra Gürster
Date Deposited: 14 Dec 2018 13:15
Last Modified: 17 Sep 2020 05:50
URI: https://pred.uni-regensburg.de/id/eprint/1265

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.